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Abstract 
People with serious mental illness (SMI) are at risk of dying many years earlier than the general population. Providing an 
effective, cost-efficient healthcare service requires a holistic approach, and improving the physical health of people with SMI 
should be integral to all healthcare roles. It is important for nurses to identify and understand the barriers that people with 
SMI may experience when accessing physical healthcare. A range of factors contribute to reduced life expectancy, including 
lifestyle factors, symptoms of mental illness and the side effects of medications. This article discusses four areas of health 
that commonly affect people with SMI: metabolic syndrome, smoking, oral health and sexual health. Metabolic syndrome is 
a cluster of risk factors that increase an individual's risk of cardiovascular disease, stroke and type 2 diabetes mellitus. 
Smoking is increasingly prevalent in people with SMI, with rates remaining steady despite a decline in smoking rates 
nationally. Oral health and sexual health can negatively affect the physical health and well-being of people with SMI; 
however, these aspects of health are often neglected. This article identifies ways that nurses in all practice settings can use 
health promotion, assessment and treatment to improve the physical health of people with SMI in relation to these four 
areas.  
 
health inequalities, health promotion, mental health, mental illness, metabolic syndrome, oral health, sexual health, 
smoking 
 
Aims and intended learning outcomes 
The aim of this article is to discuss the main issues relating to the physical health of people with serious mental 
illness (SMI) and how nurses in all practice settings can improve the health of these individuals. It considers the 
barriers to accessing physical healthcare for people with SMI, as well as metabolic syndrome, smoking, oral health 
and sexual health, including potential ways to address these issues. After reading this article and completing the time 
out activities you should be able to: 
• Identify the factors leading to a reduced life expectancy for people with SMI. 
• Outline potential barriers to accessing physical healthcare for people with SMI. 
• Describe metabolic syndrome and outline the steps that can be taken to reduce the risk of people with SMI 
developing this syndrome. 
• Identify the risks of changes to smoking frequency in people with SMI and plan appropriate care for this. 
• Provide assessment, health advice and information about management that may support smoking cessation, oral 
health and sexual health for people with SMI. 
 
Relevance to The Code 
Nurses are encouraged to apply the four themes of The Code: Professional Standards of Practice and Behaviour 
for Nurses and Midwives to their professional practice (Nursing and Midwifery Council (NMC) 2015). The themes 
are: Prioritise people, Practise effectively, Preserve safety, and Promote professionalism and trust. This article relates 
to The Code in the following ways: 
• It discusses the importance of identifying and treating the physical health needs of people with SMI. The Code 
states that nurses must make sure that people’s physical, social and psychological needs are assessed and 
responded to. 
• The Code states that nurses must pay particular attention to promoting wellbeing and preventing ill health. This 
article emphasises the importance of health promotion for people with SMI. 
• It describes the stigma that people with SMI may experience when accessing healthcare. The Code requires that 
nurses challenge discriminatory attitudes and behaviour relating to care. 
• The Code states that nurses must support those receiving care to access relevant health and social care, 
information and support. This article outlines the barriers to accessing healthcare that people with SMI may 
experience, and how nurses can reduce these.  
• It provides information about verbal and non-verbal communication skills for nurses. The Code states that nurses 
must communicate clearly and effectively. 
 
Introduction 
There is no universally agreed definition of SMI; however, the NHS Outcomes Framework (Health and Social Care 
Information Centre 2014) defined adults with SMI as ‘anyone aged 18 or over who has been in contact with 
secondary mental health services in a defined time period’. People with SMI are at risk of experiencing barriers to 
accessing healthcare and a fragmented approach to care, which may contribute to the health inequalities experienced 
by these individuals (Mental Health Taskforce 2016, Naylor et al 2016). Research has indicated that these health 
inequalities contribute to reductions in life expectancy for people with SMI of between seven and 24 years (Chesney 
et al 2014). This is an effect similar to that of smoking, and is a serious public health concern.  
It is evident that effective, cost-efficient and safe healthcare cannot be provided without a holistic approach to 
health. This is reflected in the World Health Organization (WHO) (1948) definition of health as ‘a state of complete 
physical, mental and social well-being’. Integrated services that have the potential to meet physical and mental health 
needs present the opportunity for a range of societal benefits, with Naylor et al (2016) indicating healthcare savings 
of up to £11 billion by reducing health inequalities, as well as improved quality of life and better mental and physical 
health outcomes. 
Healthcare professionals regularly come into contact with people who are affected by SMI. Nurses are well-placed 
to reduce the disparity in life expectancy and improve the overall health of people experiencing SMI. Nurses also have 
a professional duty to provide this care, outlined in The Code (NMC 2015), which states that nurses must ‘make sure 
that people’s physical, social and psychological needs are assessed and responded to’. This article discusses how 
nurses in all practice settings can enhance the physical health of people with SMI. 
Barriers to accessing physical healthcare 
People with SMI may experience barriers to accessing physical healthcare, and as a result are considerably less 
likely than the general population to have their physical health needs identified, assessed or treated (Happell et al 
2012). Happell et al (2012) identified four areas in which these individuals may experience barriers to accessing 
healthcare, including: 
• Identifying the health concern and reaching healthcare services [Q2: should this be making contact with 
healthcare services?]. 
• Arriving at the healthcare service. 
• Consulting with healthcare services. 
• Following-up the identified health concern. 
The first stage of accessing physical healthcare is recognising that there may be a health concern. There is 
evidence to suggest that some people with SMI may be unaware of physical symptoms, or only recognise them at a 
late stage, and reasons for this include: cognitive impairment associated with their mental illness; increased pain 
thresholds; social isolation; and suspicion of healthcare services (Phelan et al 2001, Samele 2004). People with SMI 
frequently have lower expectations of healthcare services and correlating higher thresholds for seeking support 
because of perceived stigma (Department of Health 2006); almost one in five people (17%) with SMI experience 
stigma when accessing physical healthcare (Lasalvia et al 2013, Harangozo et al 2014).  
There are many symptoms of mental illness that can make the process of accessing healthcare challenging. Lack of 
motivation is common in people with depression and schizophrenia, and similarly tiredness, which can make 
engaging in activity increasingly challenging, is a common side effect of many psychiatric medications (Barch 2005, 
Fava et al 2006). Social isolation and socioeconomic status can make travelling to healthcare appointments 
challenging (Phelan et al 2001).  
People with SMI have reported finding it challenging to cope with crowded and noisy waiting rooms and long 
waiting times (Lester et al 2005). These individuals are sometimes viewed as ‘difficult’ by staff in primary care, and 
conversely, people with SMI have found staff to be unhelpful and disrespectful (Happell et al 2012). These 
experiences, together with negative attitudes towards primary care, mean that people with SMI may be increasingly 
likely to seek assistance from emergency services, even when primary care is more appropriate (Happell et al 2012). 
 
TIME OUT 1 
List the barriers that someone with SMI might experience when accessing your healthcare service. What could you do 
to minimise the effects of one or more of these barriers?  
 
At an individual level, the greatest effect healthcare professionals can have on these barriers is during 
consultations. The interaction between a healthcare professional and a person with SMI can have a significant effect 
on that person’s attitudes towards accessing healthcare. Uncaring or uncompassionate behaviours [Q3: by 
healthcare professionals?] can be particularly challenging for people with SMI to manage, because they may lack 
confidence or assertiveness (Chadwick et al 2012). For some people with SMI, uncaring and dismissive attitudes can 
reinforce the belief that healthcare professionals do not believe them and that they are ‘faking’ their physical illness, 
while others may not disclose their mental illness for fear of not being believed about their physical health symptoms 
(Chadwick et al 2012). This is known as diagnostic overshadowing; when physical symptoms that should lead to 
further investigation are instead attributed to the individual’s mental illness (Nash 2013). This can be harmful 
because many physical health issues may present with psychological symptoms that are more commonly associated 
with mental illness, as shown in Table 1 (Wilber 2006, Schildkrout 2011). 
 
[Q4: can we list the physical causes for each psychological symptom in alphabetical order, i.e. Cushing’s 
syndrome, Giant cell arteritis, Hyperthyroidism etc… or is there a particular reason for the order?] 
Table 1. Psychological symptoms and possible physical causes 
Psychological symptom Possible physical causes 
Anxiety • Hyperthyroidism or hypothyroidism  
• Lupus erythematosus 
• Liver failure 
• Giant cell arteritis 
• Cushing’s syndrome 
• Insulinoma 
Cognitive changes • Multiple sclerosis 
• Parkinson’s disease 
• Dementia 
• Brain injury or infection  
• Liver disease 
• Mercury or lead poisoning 
Delirium • Urinary tract infection or dehydration, particularly in older adults 
• Non-convulsive status epilepticus 
Emotional disturbance, such 
as anger, irritability, panic, 
depression, euphoria 
• Drug or alcohol intoxication or withdrawal 
• Head injury 
• Endocrine gland disorders, for example diabetes and thyroid, parathyroid, adrenal, 
pituitary or ovarian disorders 
• Liver or kidney disease 
• Sleep disorders 
• Seizure disorders, for example epilepsy 
Hallucinations • Charles Bonnet syndrome 
• Migraine 
• Narcolepsy 
• Poisoning, for example involving lead, manganese, mercury or thallium 
• Drug or alcohol withdrawal, for example delirium tremens 
• Brain injury 
• Brain tumour or infection 
(Wilber 2006, Schildkrout 2011) 
 
TIME OUT 2 
Access the National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summaries at 
https://cks.nice.org.uk/#?char=A. Identify the symptoms of one of the physical conditions listed in Table 1. Discuss with 
a colleague why this might be mistaken for a mental illness. 
 
It is important to remember that a person with SMI may have had to overcome one or more of the previously 
mentioned barriers to attend healthcare appointments. The person’s SMI may also affect their ability to communicate 
their physical health concerns clearly and effectively (Cole and Padmanabhan 2012). In such situations, the nurse’s 
communication skills are particularly important. The communication skills listed in Table 2 are integral to nursing; 
taking the time to reflect on these is a quick and simple way to improve nursing practice. 
 
Table 2. Essential communication skills for nurses 
Skill Explanation 
Listening • Provide the person with time and space to talk 
• Listen for the underlying message in what the person is saying 
• Focus on what the person is saying by giving them your full attention 
• Tune out internal distractions, for example thinking about what to say next 
• Use verbal prompts such as ‘go on’, ‘yes’ and ‘tell me more’ 
Silence • Give the person time to communicate without feeling rushed 
• Practice to develop the ability to be still and silent 
• Wait for five seconds before asking a question, to give the person time and encourage them to 
talk 
Reflecting • Demonstrate understanding of the core message by providing feedback 
• Repeat verbatim what the person has just said 
• Paraphrase by repeating the meaning but using different words – this communicates that the 
message has been understood 
• Summarise, by providing a synopsis of what has been said 
• Reflect to enable misunderstandings to be identified 
Questioning • Use open-ended questions to invite a full response from the person, for example questions 
beginning with who, what, where, when and how? 
• Use cognitive questions, which focus on thoughts or beliefs, for example asking the person 
‘what do you think?’ 
• Use affective questions, which focus on feelings, for example asking the person ‘how did you 
feel?’ 
• Use behavioural questions, which focus on behaviour or actions, for example asking the person 
‘what did you do?’ 
• Use time-orientated questions, which focus on time – past, present and future – for example 
by asking the person ‘what did you do that helped in the past? What are you doing now that 
helps? What could you do in the future to help?’ 
• Avoid asking the person unhelpful questions, including: closed questions that require a yes or 
no response; multiple questions; asking more than one question at a time; and why questions, 
which can appear interrogative 
Non-verbal 
communication 
• Be aware of your non-verbal communication, and observe what the other person is 
communicating non-verbally 
• Use the SOLER acronym (Egan 2010) to remember the non-verbal skills that can assist 
communication: 
- S: face the other person squarely, but at a slight angle 
- O: adopt an open posture, for example do not cross your arms  
- L: lean slightly towards the person 
- E: maintain appropriate eye contact, without staring 
- R: relax posture 
(Adapted from Morrissey and Callaghan 2011)  
 
TIME OUT 3 
During the next consultation you have with a patient who you want to encourage to talk, practise waiting for five 
seconds before you speak. This may feel like a lot longer to begin with. Reflect on whether you think this was beneficial to 
the consultation. 
 
Metabolic syndrome 
Metabolic syndrome can be defined as a cluster of risk factors, including obesity, hypertension, hyperglycaemia 
and dyslipidaemia, that increase an individual’s risk of cardiovascular disease, stroke and type 2 diabetes mellitus 
(Kassi et al 2011). It has been described as one of the challenges that mental health practitioners currently 
experience, and it is thought to contribute significantly to the disparity in life expectancy between people with SMI 
and the general population (Ho et al 2014).  
Since many antipsychotic medications, in particular ‘atypical’ antipsychotic medications, are associated with an 
increased risk of metabolic syndrome, it is essential that healthcare professionals caring for those with SMI are aware 
of the potential for iatrogenic harm (De Hert et al 2012). Antipsychotic medications may increase cardiovascular risk 
by: elevating triglycerides; increasing low density lipoproteins, also known as ‘bad cholesterol’; and lowering high 
density lipoproteins, also known as ‘good cholesterol’ (British Heart Foundation 2017). These metabolic changes are 
collectively referred to as dyslipidaemia. Although the exact mechanisms of these changes remain unclear, they can 
be identified using routine blood tests and are associated with a hardening of the arteries (atherosclerosis) and the 
development of ischaemic heart disease (NICE 2014). Therefore, it is essential for healthcare professionals to 
encourage people with SMI to access physical health screening as part of holistic care. 
Obesity is another reason why people with SMI are more likely to develop metabolic syndrome than the general 
population (De Hert et al 2012). The Mental Health Foundation (2006) indicated that people experiencing mental 
illness are increasingly likely to consume diets higher in saturated fats and less likely to consume daily portions of 
fresh fruit and vegetables. Weight gain is also a commonly reported side effect of most antipsychotic medications, for 
example clozapine and olanzapine. This is thought to be partly related to the action of these medications on H1 
(histamine) receptors, resulting in significant increases in appetite (He et al 2013, British National Formulary (BNF) 
2016). Such changes are compounded by the association between atypical antipsychotic medications and 
hyperglycaemia, which is an independent risk factor for the development of type 2 diabetes (NICE 2014). Therefore, 
evidence-based nutritional advice, in combination with body mass index monitoring, should be offered to everyone 
who experiences SMI, particularly those commencing antipsychotic medication (NICE 2014). 
Promoting regular exercise is an important way in which healthcare professionals can attempt to prevent people 
with SMI from developing metabolic syndrome (Pitsavos et al 2006). Low mood, medication-related drowsiness and 
challenges accessing leisure facilities may be barriers for people with SMI who want to take part in exercise (Glover 
et al 2013, McNamee et al 2013). A sedentary lifestyle is linked to obesity, type 2 diabetes and hypertension 
(Tremblay et al 2010). It is important to note that despite the widely held belief that people with SMI are not 
responsive to advice about lifestyle changes (Wright et al 2006), there is increasing evidence to show that people 
with SMI positively engage with weight management programmes (Vreeland et al 2003, Khazaal et al 2007).  
 
TIME OUT 4 
Select one antipsychotic medication. Identify what health screening is recommended for that medication, by reading 
the NICE (2014) guideline on Psychosis and Schizophrenia in Adults: Prevention and Management or accessing the BNF 
Online at www.bnf.org/products/bnf-online, which has a section on monitoring requirements for each medication. How 
could you use this information in your consultations with patients to discuss the importance of health screening?  
 
Smoking and mental health 
A report by the Royal College of Physicians and the Royal College of Psychiatrists (2013) on the relationship 
between smoking and mental health disorders, demonstrated a strong correlation between people with SMI and the 
likelihood of smoking, indicating that people with SMI are twice as likely to smoke as the general population. While 
smoking rates have decreased among the general population, this has not been reflected in people with SMI, despite 
no differences in their motivation to stop smoking (Gilbody et al 2015). 
This is a substantial health inequality that contributes significantly to the reduced life expectancy of those with 
SMI. To reduce this disparity by improving the physical health of people with SMI, many trusts in the UK have become 
‘smoke free’, and the Mental Health Taskforce (2016) recommends that all mental health trusts become smoke free 
by 2018. 
It is important to remember that the positive benefits associated with smoking cessation, including reductions in 
depression, anxiety and stress, and improved positive mood, are as great for people with SMI as for the general 
population (Taylor et al 2014). 
 
Smoking and psychiatric medication 
P450 enzymes are the group of enzymes in the liver that are responsible for metabolising many medications. One 
of these enzymes is increased by the hydrocarbons from cigarette smoking (not found in nicotine replacement 
products), meaning that some medications are metabolised and excreted more quickly in smokers than in non-
smokers, resulting in less medication in the bloodstream. This means that an individual who smokes requires a 
higher dose of medication than if they did not smoke. Any reduction in smoking can lead to a potential increase in 
side effects because this causes reduced metabolisation and greater availability of medication in the bloodstream 
(Royal College of Physicians and Royal College of Psychiatrists 2013). Therefore, changes in smoking frequency 
should be monitored carefully. The Maudsley Prescribing Guidelines (Taylor et al 2015) recommend reducing doses 
of certain psychiatric medications by up to 25% during the first week after stopping smoking, and monitoring blood 
plasma levels at weekly intervals after stopping smoking until these levels have stabilised. 
 
TIME OUT 5 
Develop a care plan for someone with SMI who is planning to stop smoking. What factors would you consider 
important, and what support would you provide? 
 
Smoking reduction 
NICE (2013) guidelines suggest working with people to develop smoking reduction plans that include increasing 
the amount of time between cigarettes smoked to gradually reduce the frequency, choosing certain periods of the day 
to go without smoking, and delaying the first cigarette of the day for as long as possible then gradually increasing this 
delay. A brief opportunistic intervention that can be used for smoking cessation in primary care is the ‘four As’: ask, 
advise, assist and arrange (West et al 2000). All people with SMI should be asked about their smoking status, and 
follow-up assessment questions can be used to assess their smoking habits and motivation to stop smoking, such as 
(Nash 2014) [Q5: The text below has been reworked to reflect that these are questions. Is this okay?]:  
• How do you smoke? For example, do you smoke cigarettes, electronic cigarettes, shishas, unfiltered 
cigarettes or pipes? 
• How much they have per day [Q6: meaning unclear, please rewrite], including the cost and amount 
smoked per day. 
• What are your smoking habits? For example, do you smoke more or less in certain environments, or at 
particular times of day? 
• Do you want to stop smoking for good? 
• Are you interested in attempting to stop smoking in the near future? 
• Would you like support to assist you in attempting to stop smoking? 
Patients who smoke should be given advice on the benefits of smoking cessation and the potential health risks of 
continuing to smoke (Raw et al 1998). Practical assistance can be given to those who wish to stop smoking, and may 
include (Raw et al 1998): 
• Setting a date to stop smoking completely. 
• Reviewing previous attempts to stop smoking, for example what helped and hindered the attempt. 
• Identifying potential issues and planning for them, including alcohol use. 
• Advising the person to tell their family and friends [Q7: that they are planning to stop smoking?]. 
• Considering nicotine replacement therapy. 
It can be beneficial to arrange a follow-up appointment, or for those who have had several unsuccessful attempts 
to stop smoking, referral to a specialist smoking cessation service (Raw et al 1998). 
It is important to ensure the person is given information about the types of support for smoking cessation and 
what is available in their local area; even if they are not ready to change their smoking behaviour, it is important they 
are aware of the potential support available if they do become motivated to do so. People who are considering 
reducing their frequency of smoking should have access to nicotine replacement therapy, since research has 
suggested that people are twice as likely to be successful in smoking cessation using such therapy (Moore et al 2009).  
For people with SMI, it is important to notify their care coordinator, GP and any other specialist mental health 
services they attend about potential changes to their smoking frequency, to enable them to increase mental health 
monitoring and review the individual’s medication if necessary. 
 
TIME OUT 6 
Think about your attitude towards smoking cessation and mental health, and consider what effects this may have on 
the motivation of a person with SMI to reduce the frequency they smoke. Start a conversation with a person with SMI that 
explores their motivation to change their smoking behaviours. Reflect on this health promotion interaction, while taking 
into account that changing health behaviour is often not a linear process. 
 
Oral health 
People with SMI are at an increased risk of untreated dental caries, tooth loss and edentulousness (missing teeth), 
missing or ill-fitting dentures, gingivitis, periodontitis and mucosal disease (Lewis et al 2001, Ramon et al 2003, 
Kumar et al 2006, Kisely et al 2015). Suboptimal oral health, some symptoms of mental illness and side effects of 
medication can result in dental complications (Shaw and Smith 1999).  
Low mood and a lack of motivation can lead to a reduction in personal care activities including oral healthcare, 
which increases the risk of oral infections (Okoro et al 2012). Overzealous use of oral healthcare aids, such as 
toothbrushes or dental floss, can cause cervical abrasion and mucosal or gingival lacerations (Clark 2003). This can 
be associated with mania and obsessive compulsions [Q8: okay to change to obsessive-compulsive 
behaviours?]. Vomiting and malnutrition associated with some eating disorders can also significantly increase the 
risk of dental decay (Frydrych et al 2005). Side effects of medications can affect dental health. For example, one 
potential side effect of some antipsychotic and antidepressant medications is xerostomia (dry mouth), which can 
adversely affect oral health. Another potential side effect of some antipsychotic medications is tardive dyskinesia 
(involuntary face or body movements), and when this affects the mouth and facial muscles it can cause several dental 
complications, including difficulties receiving dental treatment, and ill-fitting dentures (Stanfield 2004).  
 
TIME OUT 7 
Access the electronic Medicines Compendium website at www.medicines.org.uk/emc or the BNF (2016) to identify 
which antipsychotic and antidepressant medications list xerostomia as a side effect. For each medication identify whether 
xerostomia is very common, common, uncommon, rare or very rare. How could you use this information to improve oral 
health promotion in people with SMI? 
 
While SMI can lead to suboptimal oral health, the opposite can also be the case, with suboptimal oral health being 
linked to depression. One large oral health survey in the UK found that 70% of people with suboptimal oral health 
reported that it negatively affected their lives, with 39% hiding their smile and 31% saying their teeth made them feel 
less confident in public (Dentistry.co.uk 2012).  
To improve the oral health of people with SMI, healthcare professionals should: 
• Support people to access local dental practices. 
• Use a harm minimisation strategy for those who frequently induce vomiting, encouraging them to use a 
mouthwash rather than brushing their teeth after vomiting to reduce acid exposure. 
• Be aware of xerostomia and its potential effects on oral health. Consider recommending oral lubricating gels or 
artificial saliva, which can support symptom relief, as can chewing sugarless gum to stimulate the flow of saliva.  
• Ensure individuals are aware of the recommended guidance regarding fluoride content in toothpaste. 
Recommend a ‘spit don’t rinse’ strategy after brushing teeth, which can support the remineralisation of teeth, 
thus reducing the risk of cavities (Daly 2016).  
• Provide advice on basic oral health, including brushing teeth twice a day, using floss or interdental brushes, 
reducing sugar and alcohol intake, and having regular dental check-ups.  
 
Information on basic oral healthcare is available from NHS Choices (2015).  
Sexual health 
Based on the WHO (1948) definition of health, sexual health would be defined as a state of physical, mental and 
social well-being relating to sexuality. It is important to remember that sexuality not only refers to sexual acts, but 
encompasses the person’s behaviours, desires, and attitudes related to sex and physical intimacy with others 
(National Cancer Institute 2016). Sexuality can be influenced by biological, psychological, social and cultural factors. 
Sexual dysfunction is defined by the WHO (1992) as ‘the various ways in which an individual is unable to participate 
in a sexual relationship as he or she would wish… Sexual response is a psychosomatic process and both psychological 
and somatic processes are usually involved’. 
Sexual health is an area that many healthcare professionals are reluctant to discuss with patients. Sexual issues 
are often seen as complex and sensitive, and healthcare staff may feel that they are restricted by a lack of time and 
their limited expertise (Gott et al 2004). Nurses might feel uncomfortable initiating discussions about sexual health, 
and worry that patients may also become anxious or embarrassed (Kong et al 2009). However, neglecting this area of 
health means that holistic care is not provided, and sexual health issues may be particularly important for people 
with SMI. Studies have shown that people with schizophrenia have higher levels of sexual dysfunction than the 
general population, and it is estimated to affect 30%-80% of women and 45%-80% of men (De Hert et al 2011). This 
is likely to be a side effect of antipsychotic medication; some medications have a greater effect on sexual function 
than others (Baggaley 2008). 
 Sexual dysfunction is more likely with medications that raise prolactin levels, such as amisulpride, paliperidone 
and risperidone, than those that do not, such as aripiprazole, olanzapine and quetiapine (Basson et al 2010). 
Similarly, some antidepressant medications induce or exacerbate sexual dysfunction in approximately half of patients 
(De Hert et al 2011). Despite this, patients rarely initiate discussions about these issues; therefore, it is crucial for 
healthcare professionals to actively identify the presence and extent of the person’s sexual dysfunction (Dossenbach 
et al 2005). 
A lower proportion of people with SMI are sexually active than the general population; however, those who are 
sexually active are increasingly likely to engage in risky sexual behaviours, such as unprotected sex (Cournos et al 
2005). This may be because of a lack of knowledge about sexually transmitted diseases (STDs), unwanted sexual 
activity as a result of an increased susceptibility to coercion, and comorbid alcohol and substance misuse. These risky 
behaviours increase the risk of human immunodeficiency virus (HIV) and other STDs (Robson and Gray 2007), and 
the prevalence of people who are HIV-positive among those with SMI is higher than in the general population (De 
Hert et al 2011).  
The PLISSIT model (Annon 1976) was developed to assist [Q9: healthcare professionals?] to broach the subject 
of sexual health with patients, and later this model was further developed by Davis and Taylor (2006) into the 
Extended PLISSIT (Ex-PLISSIT) model. There are four levels of intervention in the PLISSIT model: permission-giving, 
limited information, specific suggestions and intensive therapy (Box 1). While the PLISSIT model (Annon 1976) is 
linear, the Ex-PLISSIT model (Davis and Taylor 2006) suggests that the permission-giving level should be revisited at 
the start of each intervention. The Ex-PLISSIT model (Taylor and Davis 2006) [Q10: which is the correct reference 
for the Ex-PLISSIT model? Could one reference be used for consistency?] incorporates reflection and review at 
each level, enabling the nurse to develop their practice. This includes reviewing the consultation with the patient, by 
asking questions such as ‘how does that sound to you?’, ‘how might your partner feel about that?’ and ‘is there 
anything we haven’t covered?’ It is necessary for nurses to be able to reflect on their own attitudes towards sexuality, 
since the provision of effective care will not be possible if patients perceive judgement or disapproval from nurses. 
Barriers related to attitudes include: gender, with same-sex consultations being preferred; ethnicity – the belief being 
that people from some ethnic backgrounds would be more reluctant to discuss sexuality; and patients who are not 
heterosexual, where the nurse’s personal views may be challenging to reconcile with effective clinical practice (Gott 
et al 2004).  
 
Box 1. Levels of intervention in the PLISSIT model 
Permission-giving 
This level is aimed at unambiguously opening the discussion about sexual health. The nurse may think they have given the 
patient the opportunity to talk about this by asking questions such as ‘do you have any further questions?’ However, if it is 
not explicitly stated, the patient will not know that the nurse is asking about sexual health. This explicit permission-giving is 
necessary, because patients may be too embarrassed or reticent to initiate the discussion themselves. The type of questions 
to ask the patient at this level are: 
• Some people with this condition experience a loss of sexual desire or enjoyment. Is this something that you have 
experienced? 
• Sometimes people are concerned about how this condition or treatment will affect sexual functioning. Is this something 
that you are concerned about or have experienced? 
 
Limited information 
In most non-specialist settings, this level would directly follow on from the permission-giving level. This is an opportunity for 
the nurse, even with limited knowledge, to give the patient some basic information in relation to sexual health. This could 
include information about how a particular condition or treatment can affect sexual function. During this level, the nurse has 
the opportunity to correct any misinformation, dispel myths and normalise the patient’s experience, particularly in relation 
to the side effects associated with medications. The information given may be consolidated with written information in the 
form of leaflets or discussing useful websites. 
 
Specific suggestions 
In this level, the nurse requires additional skills and knowledge to take a detailed patient history and identify specific sexual 
health issues. It may be necessary to refer the patient to another healthcare professional at this level. 
 
Intensive therapy 
This level requires specialist knowledge and is usually beyond the remit of healthcare staff in non-specialist services. Nurses 
should know what specialist services are available for patient referral. This may include sexual dysfunction clinics and 
psychosexual counselling.  
(Adapted from Davis and Taylor 2006, Taylor and Davis 2006) 
 
TIME OUT 8 
Reflect on your attitudes and beliefs regarding sex and sexuality. Use the following questions as a guide: 
• Do you find it challenging to talk to patients about their sexual health? If so, why? 
• Have you made assumptions about your patients’ sexuality, for example that they are heterosexual, or that because 
they have a long-term health condition they would not be interested in sexual relationships? 
• Do you currently consider your patients’ sexuality and sexual health? If not, why do you think this is? If so, in what way 
do you do this? 
Conclusion 
There are many ways in which healthcare professionals in all practice settings can promote the physical health of 
people with SMI. Nurses should be aware of the barriers that people with SMI may experience when accessing 
physical healthcare. By considering that the person may have overcome several issues and challenges in making and 
getting to appointments, and understanding that they may not be able to communicate their concerns effectively, 
nurses are better able to provide care that is compassionate and appropriate. 
 It may be more important for people with SMI to seek physical healthcare than the general population, since 
suboptimal physical, oral and sexual health, obesity, diabetes and smoking are increasingly common in these 
individuals. They may have a range of physical health needs that are beyond those discussed in this article; there are 
many more needs that will be relevant for different areas of practice. To reduce health inequalities, it is necessary for 
healthcare professionals to examine their areas of specialty and consider how they can integrate the health 
promotion, assessment and treatment of people with SMI. 
 
TIME OUT 9 
Nurses are encouraged to apply the four themes of The Code (NMC 2015) to their professional practice. Consider how 
reducing health inequalities for people with SMI relates to the themes of The Code. 
 TIME OUT 10  
Now that you have completed the article you might like to write a reflective account as part of your revalidation. 
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